| Title |
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, February 2019
|
| DOI | 10.1007/s00262-019-02311-1 |
| Pubmed ID | |
| Authors |
Bastian Schilling, Alexander Martens, Marnix H. Geukes Foppen, Christoffer Gebhardt, Jessica C. Hassel, Elisa A. Rozeman, Anja Gesierich, Ralf Gutzmer, Katharina C. Kähler, Elisabeth Livingstone, Panagiotis T. Diamantopoulos, Helen Gogas, Gabriele Madonna, Paolo A. Ascierto, Simone M. Goldinger, Johanna Mangana, Claus Garbe, Dirk Schadendorf, Christian Blank, Benjamin Weide |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 13% |
| Student > Ph. D. Student | 4 | 11% |
| Other | 3 | 8% |
| Professor | 3 | 8% |
| Student > Doctoral Student | 3 | 8% |
| Other | 4 | 11% |
| Unknown | 16 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 32% |
| Biochemistry, Genetics and Molecular Biology | 5 | 13% |
| Mathematics | 1 | 3% |
| Nursing and Health Professions | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 16 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2019.
All research outputs
#18,009,288
of 23,130,383 outputs
Outputs from Cancer Immunology, Immunotherapy
#2,362
of 2,902 outputs
Outputs of similar age
#251,177
of 353,190 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#17
of 26 outputs
Altmetric has tracked 23,130,383 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,902 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,190 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.